Relevant bibliographies by topics / Homeopathic treatment of premenstrual syndrome

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Homeopathic treatment of premenstrual syndrome'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Homeopathic treatment of premenstrual syndrome.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Homeopathic treatment of premenstrual syndrome"

1

Colas, Aurélie, Laurence Terzan, Marie-France Bordet, and Karine Danno. "Homeopathic treatment of premenstrual syndrome: a case series." Homeopathy 102, no. 01 (January 2013): 59–65. http://dx.doi.org/10.1016/j.homp.2012.10.004.

Full text
Abstract:
Objective: Observational, prospective study to describe the homeopathic management of premenstrual syndrome (PMS) by a group of French physicians.Method: Women with PMS for >3 months were prescribed individualized homeopathic treatment. The intensity of 10 clinical symptoms of PMS was scored individually at inclusion and at a 3–6 month follow-up visit: absent = 0, mild = 1, moderate = 2, severe = 3. Total symptom score (range: 0–30) was calculated and compared for each patient at inclusion and at follow-up. PMS impact on daily activities (quality of life, QoL) was compared at inclusion and follow-up as: none, mild, moderate, severe, very severe.Results: Twenty-three women were prescribed homeopathic treatment only (mean age: 39.7 years). Folliculinum (87%) was the most frequently prescribed homeopathic medicine followed by Lachesis mutus (52.2%). The most common PMS symptoms (moderate or severe) at inclusion were: irritability, aggression and tension (87%), mastodynia (78.2%) and weight gain and abdominal bloating (73.9%); and the most common symptoms at follow-up were: irritability, aggression and tension (39.1%), weight gain and abdominal bloating (26.1%) and mastodynia (17.4%). Mean global score for symptom intensity was 13.7 at inclusion and 6.3 at follow-up. The mean decrease in score (7.4) was statistically significant (p < 0.0001). Twenty-one women reported that their QoL also improved significantly (91.3%; p < 0.0001).Conclusions: Homeopathic treatment was well tolerated and seemed to have a positive impact on PMS symptoms. Folliculinum was the most frequent homeopathic medicine prescribed. There appears to be scope for a properly designed, randomized, placebo-controlled trial to investigate the efficacy of individual homeopathic medicines in PMS.
APA, Harvard, Vancouver, ISO, and other styles
2

Yakir, M., S. Kreitler, A. Brzezinski, G. Vithoulkas, M. Oberbaum, and Z. Bentwich. "Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study." British Homeopathic Journal 90, no. 03 (July 2001): 148–53. http://dx.doi.org/10.1054/homp.1999.0491.

Full text
Abstract:
AbstractAlternative therapies in general, and homeopathy in particular, lack clear scientific evaluation of efficacy. Controlled clinical trials are urgently needed, especially for conditions that are not helped by conventional methods. The objective of this work was to assess the efficacy of homeopathic treatment in relieving symptoms associated with premenstrual syndrome (PMS). It was a randomised controlled double-blind clinical trial. Two months baseline assessment with post-intervention follow-up for 3 months was conducted at Hadassah Hospital outpatient gynaecology clinic in Jerusalem in Israel 1992–1994. The subjects were 20 women, aged 20–48, suffering from PMS. Homeopathic intervention was chosen individually for each patient, according to a model of symptom clusters. Recruited volunteers with PMS were treated randomly with one oral dose of a homeopathic medication or placebo. The main outcome measure was scores of a daily menstrual distress questionnaire (MDQ) before and after treatment. Psychological tests for suggestibility were used to examine the possible effects of suggestion. Mean MDQ scores fell from 0.44 to 0.13 (P<0.05) with active treatment, and from 0.38 to 0.34 with placebo (NS). (Between group P=0.057). Improvement >30% was observed in 90% of patients receiving active treatment and 37.5% receiving placebo (P=0.048). Homeopathic treatment was found to be effective in alleviating the symptoms of PMS in comparison to placebo. The use of symptom clusters in this trial may offer a novel approach that will facilitate clinical trials in homeopathy. Further research is in progress.
APA, Harvard, Vancouver, ISO, and other styles
3

Klein-Laansma, Christien T., Alexander L. B. Rutten, Jean Pierre C. H. Jansen, Herman van Wietmarschen, and Miek C. Jong. "Evaluation of a Prognostic Homeopathic Questionnaire for Women with Premenstrual Disorders." Complementary Medicine Research 25, no. 3 (2018): 173–82. http://dx.doi.org/10.1159/000487318.

Full text
Abstract:
Background/Aims: Validation of treatments with individually prescribed homeopathic medicines is a challenging task. A prognostic homeopathic patient questionnaire containing 140 keynote symptoms (highly characteristic of a specific homeopathic medicine) and an electronic algorithm to process the answers were used in 2 clinical studies. The algorithm outcome, based on total symptom scores, indicated 1 of 11 pre-selected homeopathic medicines for women with premenstrual syndrome and premenstrual dysphoric disorder (PMS/PMDD). Aims were (1) to estimate the prognostic values of keynote symptoms and (2) to evaluate the reliability of the homeopathic medicine ranking in the algorithm outcome. Methods: The prevalence of specific keynote symptoms was calculated in 145 women diagnosed with PMS/PMDD and in 40 included women with favorable outcomes using 1 of the 11 homeopathic medicines. Likelihood ratios (LRs) of the keynote symptoms were calculated. Pearson's correlations were calculated between 2 sets of total algorithm scores for 11 homeopathic medicines, obtained at 2 time points. Results: (1) A positive prognostic value (LR ≥ 1.5) was found in 34 keynote symptoms with a prevalence of 10-40%, with 10 symptoms already being connected to the corresponding homeopathic medicine in the algorithm. For example, the symptom ‘common cold of the nose before menstruation' indicated Magnesium carbonicum with LR = 7.47 (confidence interval (CI) 3.90-14.28). (2) Pearson's correlations for the reliability evaluation varied from 0.69 to 0.84. Conclusions: Recommendations can be made to improve the PMS algorithm with more accurate keynote symptoms. The prognostic questionnaire proved a reliable tool to rank 11 homeopathic medicines by total scores, based on keynote symptoms. This PMS algorithm can be used for the treatment of PMS/PMDD in clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
4

Yakir, Michal, Christien T. Klein-Laansma, Shulamith Kreitler, Amnon Brzezinski, Menachem Oberbaum, George Vithoulkas, and Zvi Bentwich. "A Placebo-Controlled Double-Blind Randomized Trial with Individualized Homeopathic Treatment Using a Symptom Cluster Approach in Women with Premenstrual Syndrome." Homeopathy 108, no. 04 (August 21, 2019): 256–69. http://dx.doi.org/10.1055/s-0039-1691834.

Full text
Abstract:
Background In a double-blind placebo-controlled randomized trial with parallel groups, the efficacy of individually prescribed homeopathic medicines was evaluated in women with premenstrual syndrome (PMS). Methods In an outpatient department of a university clinic in Jerusalem, Israel (1996–1999), women with PMS, aged 18 to 50 years, entered a 2-month screening phase with prospective daily recording of premenstrual symptoms by the Menstrual Distress Questionnaire (MDQ). They were included after being diagnosed with PMS. A reproducible treatment protocol was used: women received a homeopathic prescription based on symptom clusters identified in a questionnaire. The symptoms were verified during a complementary, structured, interview. Only women whose symptoms matched the symptom profile of one of 14 pre-selected homeopathic medicines were included. Each participant was administered active medicine or placebo via random allocation. Primary outcome measures were differences in changes in mean daily premenstrual symptom (PM) scores by the MDQ. Analysis was by intention-to-treat. Results A total of 105 women were included: 49 were randomized to active medicine and 56 to placebo. Forty-three women in the active medicine group and 53 in the placebo group received the allocated intervention with at least one follow-up measurement and their data were analyzed. Significantly greater improvement of mean PM scores was measured in the active medicine group (0.443 [standard deviation, SD, 0.32] to 0.287 [SD, 0.20]) compared to placebo (0.426 [SD, 0.34] to 0.340 [SD, 0.39]); p = 0.043. Conclusions Individually prescribed homeopathic medicines were associated with significantly greater improvement of PM scores in women with PMS, compared to placebo. Replication, with larger sample size and other refinements, is recommended to confirm the efficacy of this treatment in other settings.
APA, Harvard, Vancouver, ISO, and other styles
5

Klein-Laansma, C. T., J. C. H. Jansen, A. J. W. van Tilborgh, D. A. W. M. Van der Windt, R. T. Mathie, and A. L. B. Rutten. "Semi-standardised homeopathic treatment of premenstrual syndrome with a limited number of medicines: Feasibility study." Homeopathy 99, no. 3 (July 2010): 192–204. http://dx.doi.org/10.1016/j.homp.2010.05.007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wandile, Pranali. "Fibromyalgia Management with Homeopathy." Homœopathic Links 30, no. 04 (December 2017): 245–49. http://dx.doi.org/10.1055/s-0037-1608614.

Full text
Abstract:
AbstractFibromyalgia is one of the most common genetically inherited chronic affective spectrum disorders (ASD). Other ASD disorders are psychiatric and medical conditions such as irritable bowel syndrome (IBS), migraine, cataplexy—attention-deficit/hyperactivity disorder, bulimia nervosa, dysthymic disorder, generalised anxiety disorder, major depressive disorder (MDD), obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder, rheumatoid arthritis, and social phobia. Apart from genetic factors, neuroendocrine, autonomic nervous system abnormalities, psychosocial variables and environmental stressors contribute in the pathophysiology of fibromyalgia and other associated disorders. In this article, we reviewed etiology, pathophysiology, maintaining and triggering factors, and various treatment options for fibromyalgia. Apart from the pain management, this condition can be managed by ancillary method of treatment. However, due to the genetic cause of the disease, there is very little to offer for its complete cure. Homeopathic miasmatic treatment focuses on the genetic cause of the disease for its complete annihilation while also providing various acute remedies for the temporary pain management. We reviewed homeopathy treatment management and various remedies, which have much to offer for this chronic condition while considering its genetic, triggering and maintaining factors.
APA, Harvard, Vancouver, ISO, and other styles
7

Jones, Angela. "Homeopathic treatment for premenstrual symptoms." Journal of Family Planning and Reproductive Health Care 29, no. 1 (January 1, 2003): 25–28. http://dx.doi.org/10.1783/147118903101196855.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Cox, Michael. "Size does matter and Homeopathic treatment of premenstrual symptoms." Journal of Family Planning and Reproductive Health Care 29, no. 3 (July 1, 2003): 172. http://dx.doi.org/10.1783/147118903101197719.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dennerstein, Lorraine, Carol Morse, Gordon Gotts, James Brown, Margery Smith, Jeremy Oats, and Graham Burrows. "Treatment of premenstrual syndrome." Journal of Affective Disorders 11, no. 3 (November 1986): 199–205. http://dx.doi.org/10.1016/0165-0327(86)90070-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Tucker, Joan S., and Richard E. Whalen. "Premenstrual Syndrome." International Journal of Psychiatry in Medicine 21, no. 4 (December 1991): 311–41. http://dx.doi.org/10.2190/1cet-d610-uheb-yng6.

Full text
Abstract:
The Premenstrual Syndrome (PMS) was described as a unique entity meriting therapeutic attention in 1931. Although researchers in the area have failed to develop a widely accepted definition of PMS, substantial progress has been made in describing the variety of psychobiological profiles encompassed by this syndrome, particularly with respect to its typical symptoms, cyclical nature, symptoms recurrence and severity. Therapies ranging from diet and exercise to vitamin, hormone and drug treatment have been proposed. While none is more efficacious than placebo, several have been popularized. Our failure to develop adequate treatment may reflect our lack of understanding of either the psychosocial or biological factors involved in PMS. This, in turn, may reflect inadequate theoretical development in this research area. We provide a critical assessment of research on PMS, suggest a framework for theoretical development and advocate research strategies that might provide insights into the etiology of the premenstrual syndrome.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Homeopathic treatment of premenstrual syndrome"

1

Souza, Miriam Coelho de. "Magnesium supplementation in treatment of premenstrual syndrome." Thesis, University of Reading, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.363772.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Canning, Sarah Elizabeth. "The premenstrual syndrome : characterisation, diagnosis and treatment." Thesis, University of Leeds, 2008. http://etheses.whiterose.ac.uk/622/.

Full text
Abstract:
Premenstrual syndrome (PMS) is a prevalent condition. Key symptoms which promote treatment seeking are primarily psychological e. g. depression and aggression. Sufferers are often reluctant to take prescribed medication and often purchase dietary supplements and herbal remedies over the counter for which the evidence base with regards efficacy is limited. The primary aim of this thesis was to examine the effectiveness of St. John's Wort (SJW) for PMS. Proposals that this herbal remedy could benefit PMS symptoms are based on evidence that SJW increases serotonin levels and suppresses pro-inflammatory cytokine production. Following a systematic review which demonstrated that although calcium and continuous vitamin B6 administration confer some benefit for premenstrual symptoms, the evidence for most dietary supplements and herbal remedies including SJW is conflicting or insufficient, a ten-cycle randomised double-blind, placebocontrolled, crossover trial was conducted. PMS sufferers (NIMH, 1983) were administered 900mg SJW/day (0.18% hypericin; 3.38% hyperforin) for two menstrual cycles (n=34). SJW was found to benefit physical and behavioural PMS symptoms, but did not significantly improve mood or pain symptoms. A comparison of various commonly used analytical strategies performed on the data highlighted the need for a consensus to be reached regarding the way in which researchers assess treatment efficacy. Hormone (FSH, LH, oestradiol, progesterone, prolactin and testosterone) and cytokine (IL-1p, IL-6, IL-8, IFN-y and TNF-a) levels were assessed in women with and without PMS during the follicular and luteal phases, and were also studied in PMS sufferers taking SJW and placebo treatment. The hormone and cytokine profiles of PMS sufferers during SJW and placebo treatment did not differ. However, PMS sufferers exhibited significantly greater testosterone and cytokine (IL-6,11-8 and TNF-a) levels than normally cycling women who did not self-report problematic PMS symptoms across the cycle, suggesting that these mechanisms may be involved in the aetiology of the syndrome. To ensure the scientific quality of the clinical trial, certain methodological considerations were explored. PMS is diagnosed in various ways, which has resulted in PMS studies being conducted on heterogeneous samples of women, who are often not analogous to women requiring treatment in clinical practice. This study highlighted the need for researchers to use a diagnostic procedure that identifies PMS sufferers experiencing PMS symptoms at a severity appropriate to address the aim of their study, and that differentiates women with PMS from those with clinical anxiety and depression. Moreover, the DSR (Freeman et al., 1996) was refactor analysed and a two factor solution was produced, the DSR-20. This new measure was shown to be a more sensitive tool than the original DSR to assess treatment effects in the sample recruited for this research. Collectively these findings could improve future diagnostic and therapeutic strategies.
APA, Harvard, Vancouver, ISO, and other styles
3

Kudlas, Jane Michele. "Low-fat diet vs. education support in the treatment of late luteal phase dysphoric disorder." Diss., Virginia Tech, 1992. http://hdl.handle.net/10919/39719.

Full text
Abstract:
A treatment outcome study was conducted comparing a low-fat diet intervention with an education-support group and a waiting-list control group in the treatment of premenstrual tension syndrome (PMS) or Late Luteal Phase Dysphoric Disorder (LLPDD). Subjects met provisional diagnostic criteria for LLPDD and symptoms were monitored prospectively. A low-fat diet was hypothesized too be an effective intervention for reducing the severity of both physical and emotional symptoms in women suffering from LLPDD. This was based on the theory relating raised estrogen levels to premenstrual distress, and research suggesting low-fat diets reduce estrogen levels. The hypothesis that a low-fat diet would decrease premenstrual suffering was not supported by the results of this study. However, there appeared to be an advantage to participating in a group which provided support and information on LLPDD compared to receiving no treatment. Implications for future research, treatment recommendations, and methodological issues are discussed.
Ph. D.
APA, Harvard, Vancouver, ISO, and other styles
4

Magos, Adam Laszlo. "Diagnosis of the premenstrual syndrome, and treatment with subcutaneous crystalline implants of oestradiol." Thesis, King's College London (University of London), 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.420878.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Eriksson, Olle. "Studies on Premenstrual Dysphoria." Doctoral thesis, Uppsala : Acta Universitatis Upsaliensis : Univ.-bibl. [distributör], 2005. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5812.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Graham, Cynthia Anne. "Treatment of premenstrual syndrome with a triphasic oral contraceptive : a double-blind placebo-controlled trial." Thesis, McGill University, 1989. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=74262.

Full text
Abstract:
Two studies are presented which investigated the relationship between oral contraceptives (o.c.s) and premenstrual changes in mood and physical state. The retrospective pilot study examined possible differences in symptom-reporting between groups of pill-users and non-users. Women using o.c.s had lower severity scores on a number of physical and mood-related symptoms compared to non-users. In the prospective study, eighty-two women with complaints of moderate to severe premenstrual symptoms were recruited for a double-blind, controlled trial of a triphasic o.c. Subjects made daily ratings of symptoms for one to two baseline cycles and were then randomly assigned to receive either placebo or the o.c. for three treatment cycles. Prospective assessment of symptoms was made using a variety of measures, and circulating levels of estrogen and progesterone were measured at three points during the cycle. Bloating and breast pain showed a greater reduction in the o.c. group than in the placebo group. In a subgroup of women with premenstrual depressive change, the o.c. also produced greater improvement in a number of symptoms compared to placebo. For all other symptoms, there was no beneficial effect of the active treatment over placebo. Women who received o.c.s reported decreased sexual interest after starting the pill. Possible hormonal mechanisms for these effects are discussed.
APA, Harvard, Vancouver, ISO, and other styles
7

Frank, Beth. "Conjoint treatment : impact on married couples with and without PMS." Virtual Press, 1994. http://liblink.bsu.edu/uhtbin/catkey/917831.

Full text
Abstract:
The goal of this study was to investigate the efficacy of a marital systems approach to the treatment of women with self-referred premenstrual syndrome. The first purpose of the study was to identify any significant differences on the Global Distress Scale of the Marital Satisfaction Inventory and the Causal Dimension Scale between (PMS+) and (PMS-) married couples before and after marital treatment. The second purpose of the study was to determine any significant differences on dependent measures of averaged marital ratings between (PMS+) and (PMS-) wives during thecycle ratings between (PMS+) and (PMS-) wives.Nine married couples participated in a group comparison study through Community Hospitals of Indianapolis, Indiana. The study was conducted in two phases, including a three month assessment phase followed by a two month treatment phase. Four married couples whose wives met the DSM-III-R's diagnostic criteria for Late Luteal Phase Dysphoric Disorder were included in the (PMS+) group. Five married couples whose wives did not meet the diagnostic criteria for LLPDD were included in the (PMS-) comparison group.Statistical analyses revealed significant time effects; assessment and treatment purpose of the study was differences on dependent phase of the study. The third to identify any significant measures of averaged menstrual no three-way or two-way interactive effects for any of the three hypotheses. The results clinically support the notion of treating marriages with PMS versus solely treating women with PMS. Regardless of whether wives prospectively confirmed premenstrual symptoms, treatment involving the marriage impacted menstrual cycle symptom ratings and perceptions of the marriage positively.
Department of Counseling Psychology and Guidance Services
APA, Harvard, Vancouver, ISO, and other styles
8

Patel, Reshma. "The effect of the homeopathic simillium on white females suffering with symptoms of premenstrual syndrome using ten case studies." Thesis, 2011. http://hdl.handle.net/10210/3725.

Full text
Abstract:
M.Tech.
Premenstrual syndrome (PMS) is a group of physical and psychological symptoms that occur cyclically in females. It is of unknown aetiology. These symptoms occur specifically during the luteal phase (from day 14 to day 1 of the next menstrual cycle) and are resolved over the course or at the onset of menstruation (Indusekhar et al., 2007). The syndrome is characterised by irritability, depression, anxiety, headache, abdominal bloating, breast tenderness, breast swelling, changes in appetite, acne, and weight gain due to oedema. Mild physiological symptoms are experienced by approximately 95% of all women of reproductive age and about 5% of symptomatic women complain of extremely severe symptoms, called premenstrual dysphoric disorder (PMDD), that disrupt their daily living (Wyatt, 1999). Deuster et al., (1999) note that PMS is prevalent in all demographic groups, however differences in races do exist and their research shows that black women are more likely to suffer from PMS than women of other races. The current conventional treatment options are limited, not always effective and sometimes have significant side effects (Ross et al., 2000). Complementary and alternative treatments are said to be beneficial, however sufficient quality trials are required to substantiate their claims to efficacy (Indusekhar et al., 2007). Research into the use of individualised homeopathy in PMS has been shown to have positive results (Yakir et al., 2001). The aim of this four month study was to determine the efficacy of the homeopathic simillimum in the treatment of premenstrual syndrome in white females. This study will eventually provide the material to compare the presentation of PMS, and the effect of the homeopathic simillimum in different race groups. The following symptoms were evaluated 14 days before menstruation: irritability, depression, anxiety, headache, abdominal bloating, breast tenderness, breast swelling, and food cravings (Beers et al., 2003). Volunteers were asked to complete a selection questionnaire, in order for them to take part in the study. If they qualified to take part in this study a full case history was then taken for each participant using the standard homeopathic clinic case form. In this four month case study each of the ten participants completed a PMS chart for each month grading their symptoms on a daily basis and recording their dates of menstruation. A baseline of each participant’s premenstrual symptoms was established by an initial treatment-free month where a PMS chart had to be completed to score the participants’ daily symptoms. Thereafter the participants were treated using homeopathic simillimum treatment for the remaining three months. The chart required each participant to score the severity of the eight different premenstrual symptoms that they experience on a scale of 0 to 5 (0 indicated that the symptom was not present, and 5 indicated that the symptom was very severe). These charts were collected at the end of each cycle. At the end of the trial these PMS charts were submitted for statistical analysis. These results were analysed by using the non parametric Wilcoxon Signed Ranks Test by comparing the severity of symptoms experienced in the premenstrual period (14 days before menstruation) for each of the three months of treatment to the initial treatment-free month. These results showed that the homeopathic simillimum was statistically significant in the treatment of the symptoms of PMS in these white females.
APA, Harvard, Vancouver, ISO, and other styles
9

Komar, Tania. "A qualitative study to determine the efficacy of the homoeopathic similimum in the treatment of premenstrual syndrome." Thesis, 2009. http://hdl.handle.net/10210/2608.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sarawan, Shanie. "An evaluation of the efficacy of a homeopathic complex, Premenstron, in the treatment of premenstrual syndrome in terms of the patients' perception." Thesis, 2001. http://hdl.handle.net/10321/2173.

Full text
Abstract:
Dissertation submitted in partial compliance with the Requirements for the Master's Degree in Technology: Homeopathy, Technikon Natal, 2001.
The purpose of this double -blind placebo-control1ed study was to evaluate the efficacy of a homeopathic complex, Premenstron\xAE, in the treatment of premenstrual syndrome in terms of the patients' perception of the efficacy of the treatment. Thirty-four patients were selected from volunteers who met the diagnostic criteria developed by Dalton (1984: 19). Of these patients thirty completed the study. These patients were divided into two groups according to simple random sampling. Data was collected at the Homeopathic Day Clinic at Technikon Natal. Half of the patients received a placebo and the other half received the homeopathic complex. Patients were treated over a period of approximately two months (three consultations ). The patients completed the Moos Menstrual Distress Questionnaire at each consultation. The questionnaire consists of 47 symptoms grouped into eight subscales. Results were analysed statistically using the Mann Whitney unpaired test (inter-group comparison) and the Wilcoxon's sign rank test (intra-group comparison). When the three questionnaires for each patient were compared, it was found that the placebo group did improve in the second consultation (P= 0.016) but the placebo effect did not last through to the third consultation. The treatment group
M
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Homeopathic treatment of premenstrual syndrome"

1

Dalton, Katharina. PMS: The essential guide to treatment options. London: Thorsons, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

The natural way premenstrual syndrome. Rockport, Mass: Element, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Martorano, Joseph T. Unmasking PMS: The complete PMS medical treatment plan. New York: M. Evans & Co., 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dalton, Katharina. A guide to premenstrual syndrome and its treatment. [London]: The Author, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Payne, Elizabeth Susan. The diagnosis and treatment of the premenstrual syndrome. Birmingham: University of Birmingham, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kallins, George J. 5 steps to a PMS-free life: The groundbreaking new program that stops the monthly roller coaster and puts you in control. Laguna Niguel, CA: Village Healer Press, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Donald, Lombard, and Horrobin David F, eds. The PMS solution: Premenstrual syndrome, the nutritional approach. Montréal: Eden Press, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nazzaro, Ann. The PMS solution: Premenstrual syndrome, the nutritional approach. Minneapolis, Minn: Winston Press, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Beat PMT through diet: The PMT Advisory Service programme based on medically proven treatment. London: Ebury Press, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Stewart, Maryon. Beat PMT through diet: The Women's Nutritional Advisory Service programme based on medically proven treatment. London: Vermilion, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Homeopathic treatment of premenstrual syndrome"

1

Parlee, Mary Brown. "Media Treatment of Premenstrual Syndrome." In Premenstrual Syndrome, 189–205. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5275-4_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Reid, Robert L. "Pathophysiology and Treatment of Premenstrual Syndrome." In Premenstrual Syndrome, 329–50. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5275-4_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

O’ Brien, P. M. S. "Controversies in Premenstrual Syndrome: Etiology and Treatment." In Premenstrual Syndrome, 317–28. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5275-4_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Blechman, Elaine A., and Connie J. Clay. "The Scientific Method and Ethical Treatment of Premenstrual Complaints." In Premenstrual Syndrome, 223–36. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4684-5275-4_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Shoupe, Donna. "Diagnosis and Treatment of Premenstrual Syndrome." In Handbook of Gynecology, 181–85. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-17798-4_33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shoupe, Donna. "Diagnosis and Treatment of Premenstrual Syndrome." In Handbook of Gynecology, 1–5. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-17002-2_33-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cioni, F., and F. Ferraroni. "8. Vitamin D and other nutrients in the treatment of premenstrual syndrome." In Handbook of diet and nutrition in the menstrual cycle, periconception and fertility, 121–36. The Netherlands: Wageningen Academic Publishers, 2014. http://dx.doi.org/10.3920/978-90-8686-767-7_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bancroft, John, Harry Boyle, and Hamish Fraser. "The use of an LHRH Agonist in the Treatment and Investigation of the Premenstrual Syndrome." In Neuroendocrine Molecular Biology, 465–73. Boston, MA: Springer US, 1986. http://dx.doi.org/10.1007/978-1-4684-5131-3_40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Mishra, Jagdishwari, and Rita Jha. "Premenstrual Syndrome." In Treatment and Prognosis in Obstetrics and Gynecology, 275. Jaypee Brothers Medical Publishers (P) Ltd., 2014. http://dx.doi.org/10.5005/jp/books/12198_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Roberts, Laura Weiss, Teresita McCarty, and Sally K. Severino. "Premenstrual Syndrome Treatment Interventions." In Assessment and Therapy, 245–60. Elsevier, 2001. http://dx.doi.org/10.1016/b978-012267806-6/50055-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Homeopathic treatment of premenstrual syndrome"

1

Naik, Sujata. "The Homeopathic Approach to Treatment of Polycystic Ovarian Syndrome in a Rural Set-up." In HRI London 2019—Cutting Edge Research in Homeopathy: Presentation Abstracts. The Faculty of Homeopathy, 2020. http://dx.doi.org/10.1055/s-0040-1702120.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Homeopathic treatment of premenstrual syndrome' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography